The proline form of p53 codon 72 polymorphism is associated with endometriosis

被引:73
作者
Chang, CC
Hsieh, YY
Tsai, FJ
Tsai, CH
Tsai, HD
Lin, CC
机构
[1] China Med Coll Hosp, Dept Pediat & Med Genet, Taichung, Taiwan
[2] China Med Coll Hosp, Dept Pediat & Med Genet, Taichung, Taiwan
[3] China Med Coll Hosp, Dept Family Med, Taichung, Taiwan
[4] Li Shin Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
关键词
arginine form; endometriosis; polymorphism; proline form; p53;
D O I
10.1016/S0015-0282(01)02938-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the association between endometriosis and the p53 polymorphism. Design: Prospective study. Setting: Department of gynecology and genetics in a medical center. Patient(s): Women with and without endometriosis. Intervention(s): Women were categorized as having moderate or severe endometriosis (n = 118) or no endometriosis (n = 140). Main Outcome Measure(s): Polymerase chain reaction was used to detect p53 codon 72 polymorphisms (arginine homozygosity, heterozygosity, and proline homozygosity). Associations between endometriosis and p53 polymorphisms were evaluated. Result(s): The distributions of different p53 polymorphisms differed significantly between groups. The respective proportions of arginine homozygotes, heterozygotes, and proline homozygotes were 10.2%, 66.9%, and 22.9% in the group with endometriosis and 30.7%, 50%, and 19.3% in the group without endometriosis. Conclusion(s): Endometriosis is associated with p53 polymorphism, p53 arginine homozygotes have lower risk for endometriosis. Heterozygotes and proline homozygotes have higher risk for endometriosis. (Fertil Steril(R) 2002;77:43-5. (C) 2002 by American Society for Reproductive Medicine.).
引用
收藏
页码:43 / 45
页数:3
相关论文
共 30 条
[1]   CODON-72 POLYMORPHISM OF THE TP53 GENE [J].
ARA, S ;
LEE, PSY ;
HANSEN, MF ;
SAYA, H .
NUCLEIC ACIDS RESEARCH, 1990, 18 (16) :4961-4961
[2]   Heritability and molecular genetic studies of endometriosis [J].
Bischoff, FZ ;
Simpson, JL .
HUMAN REPRODUCTION UPDATE, 2000, 6 (01) :37-44
[3]  
Boley SE, 2000, CANCER RES, V60, P2831
[4]   Alterations of Adenomatous Polyposis Coli (APC) gene in oral squamous cell carcinoma [J].
Chang, KW ;
Lin, SC ;
Mangold, KA ;
Jean, MS ;
Yuan, TC ;
Lin, SN ;
Chang, CS .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (03) :223-226
[5]   Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumor [J].
Chen, WC ;
Tsai, FJ ;
Wu, JY ;
Wu, HC ;
Lu, HF ;
Li, CW .
UROLOGICAL RESEARCH, 2000, 28 (05) :293-296
[6]   High level expression of ΔN-p63:: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? [J].
Crook, T ;
Nicholls, JM ;
Brooks, L ;
O'Nions, J ;
Allday, MJ .
ONCOGENE, 2000, 19 (30) :3439-3444
[7]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[8]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327
[9]  
Helland Å, 1998, NATURE, V396, P530, DOI 10.1038/25034
[10]   Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of α-fetoprotein, sex steroid receptors, and p53 [J].
Horiuchi, A ;
Osada, R ;
Nakayama, K ;
Toki, T ;
Nikaido, T ;
Fujii, S .
GYNECOLOGIC ONCOLOGY, 1998, 70 (02) :295-299